Responses
Other content recommended for you
- Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson’s disease and proposed criteria for use of sham surgery controls
- Sham neurosurgery in patients with Parkinson's disease: is it morally acceptable?
- Human-specific duplicate CHRFAM7A gene is associated with more severe osteoarthritis and amplifies pain behaviours
- Blocking the tropomyosin receptor kinase A (TrkA) receptor inhibits pain behaviour in two rat models of osteoarthritis
- The potential benefit of the placebo effect in sham-controlled trials: implications for risk-benefit assessments and informed consent
- Parental obligation and compelled caesarean section: careful analogies and reliable reasoning about individual cases
- Finnish Degenerative Meniscal Lesion Study (FIDELITY): a protocol for a randomised, placebo surgery controlled trial on the efficacy of arthroscopic partial meniscectomy for patients with degenerative meniscus injury with a novel ‘RCT within-a-cohort’ study design
- Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson’s disease
- Overdiagnosis, ethics, and trolley problems: why factors other than outcomes matter—an essay by Stacy Carter
- A case for justified non-voluntary active euthanasia: exploring the ethics of the Groningen Protocol